Revenues as Reported
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Net revenues experienced a peak in 2020 at US$ 26,153 million, followed by a three-year period of consistent contraction, concluding at US$ 24,483 million in 2023. This overall downward trajectory is primarily driven by a decline in the core smokeable products segment, which partially offsets the growth observed in oral tobacco products.
- Smokeable Products Performance
- As the dominant revenue stream, smokeable products peaked in 2020 at US$ 23,089 million. Since that peak, the segment has undergone a steady decline for three consecutive years, falling to US$ 21,756 million by the end of 2023. This trend indicates a systemic reduction in the primary source of income for the organization.
- Oral Tobacco Products Growth
- Oral tobacco products demonstrated a positive growth trajectory over the analyzed period. Revenues increased from US$ 2,367 million in 2019 to US$ 2,667 million in 2023. This segment shows resilience and serves as a partial hedge against the losses sustained in the smokeable products category.
- Wine Segment Contraction and Exit
- The wine segment showed a continuous decline in revenue from US$ 689 million in 2019 to US$ 494 million in 2021. The absence of reported revenue for this item in 2022 and 2023 suggests a strategic cessation of operations or a divestment of this business line.
- Miscellaneous Revenue Volatility
- Revenues categorized as "All other" remained immaterial to the total financial profile. This segment was characterized by significant volatility, including a negative value of US$ 83 million in 2020, before recovering to US$ 60 million in 2023.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?